Multiparametric Contrast-Free MRI Successfully Identifies Venous Thrombus Responsive to Lytic Therapy: From Mice to Humans
Circulation: Cardiovascular Imaging · 2025-11 · 18 (11)
DOI: 10.1161/circimaging.125.018175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Imaging, 2025-11. Verfasst von Justinas Silickas und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular and Metabolic Medicine & Sciences (J.S., A.S., B.M., A.S.P., S.B.), Kings College London, UK. Hauptthemen laut MEDLINE: Venous Thrombosis, Thrombolytic Therapy, Vena Cava, Inferior, Fibrinolytic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Randomized trials of venous thrombolysis to prevent postthrombotic syndrome have produced mixed results. A method to identify patients most likely to benefit from interventional treatment is needed. This study evaluated a contrast-free, magnetic resonance-based multisequence thrombus imaging (MSTI) technique to characterize deep venous thrombi and predict susceptibility to thrombolysis. METHODS: Venous thrombosis was induced in the inferior vena cava of BALB/C mice (n=56, male), which were imaged up to 28 days postsurgery and 24 hours after systemic thrombolysis (Actilyse, 10 mg/kg, IV). The prelysis MSTI protocol included 3-dimensional T1 mapping, 3-dimensional magnetization transfer, and 2-dimensional diffusion-weighted imaging. Thrombolysis was defined as successful if inferior vena cava blood flow increased by ≥50% compared with prelysis values. In a clinical cohort, 41 patients with acute iliofemoral deep venous thrombi underwent MSTI before catheter-directed thrombolysis. Imaging parameters were analyzed against postintervention outcomes. RESULTS: MSTI identified thrombi susceptible to thrombolysis in both mice and humans. In mice, lysed thrombi showed lower T1 (723 [667–782] versus 874 [799–1000] ms; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Cardiovascular and Metabolic Medicine & Sciences (J.S., A.S., B.M., A.S.P., S.B.), Kings College London, UK.
- Radiology Department, School of Medicine, Pontificia Universidad Católica de Chile, Santiago (M.E.A.).
- Millennium Institute for Intelligent Healthcare Engineering, Santiago, Chile (M.E.A., R.M.B.).
- Escuela de Ingeniería (M.E.A.), Pontificia Universidad Católica de Chile, Santiago.
- School of Biomedical Engineering and Imaging Sciences, Research Department of Cardiovascular Imaging (R.M.B., N.K., P.S.), Kings College London, UK.
- Institute for Biological and Medical Engineering (R.M.B), Pontificia Universidad Católica de Chile, Santiago.
ORCID-Profile: Justinas Silickas, Marcelo E Andia, René M Botnar, Bijan Modarai, Prakash Saha
Zitieren
APA
Silickas, J., Smith, A., Andia, M. E., Botnar, R. M., Modarai, B., Karunanithy, N., Patel, A. S., Black, S., Saha, P., & Phinikaridou, A. (2025). Multiparametric Contrast-Free MRI Successfully Identifies Venous Thrombus Responsive to Lytic Therapy: From Mice to Humans. Circulation: Cardiovascular Imaging, 18(11). https://doi.org/10.1161/circimaging.125.018175
Vancouver
Silickas J, Smith A, Andia ME, Botnar RM, Modarai B, Karunanithy N, et al. Multiparametric Contrast-Free MRI Successfully Identifies Venous Thrombus Responsive to Lytic Therapy: From Mice to Humans. Circulation: Cardiovascular Imaging. 2025;18(11). doi:10.1161/circimaging.125.018175
BibTeX
@article{Silickas2025,
author = {Silickas, Justinas and Smith, Alberto and Andia, Marcelo E and Botnar, René M and Modarai, Bijan and Karunanithy, Narayan and Patel, Ashish S and Black, Stephen and Saha, Prakash and Phinikaridou, Alkystis},
title = {Multiparametric Contrast-Free MRI Successfully Identifies Venous Thrombus Responsive to Lytic Therapy: From Mice to Humans},
journal = {Circulation: Cardiovascular Imaging},
year = {2025},
volume = {18},
number = {11},
doi = {10.1161/circimaging.125.018175}
}
EUVIMED